Patents by Inventor Jimmy Y. Yu

Jimmy Y. Yu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Molecules for disease detection and treatment
    Publication number: 20040142331
    Abstract: The present invention provides purified disease detection and treatment molecule polynucleotides (mddt). Also encompassed are the polypeptides (MDDT) encoded by mddt. The invention also provides for the use of mddt, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing mddt for the expression of MDDT. The invention additionally provides for the use of isolated and purified MDDT to induce antibodies and to screen libraries of compounds and the use of anti-MDDT antibodies in diagnostic assays. Also provided are microarrays containing mddt and methods of use.
    Type: Application
    Filed: August 11, 2003
    Publication date: July 22, 2004
    Inventors: Stuart E Jackson, Stephen E Lincoln, Christina M Altus, Gerard E Dufour, Michael S Chalup, Jennier L Jackson, Anissa L Jones, Jimmy Y Yu, Rachel J Wright, Darryl Gietzen, Tommy F Liu, Pierre E Yap, Christopher R Dahl, Monika G Momiyama, Diana L Bradley, Sameer D Rohatgi, Bernard Harris, Ann M Roseberry Lincoln, Edward H Gerstin, Careyna H Peralta, Marie H David, Scott R Panzer, Vincent Z Flores, Abel Daffo, Rakesh Marwaha, Alice J Chen, Simon C Chang, Alan P Au, Rebekah R Inman
  • Molecules for diagnostics and therapeutics
    Publication number: 20040048253
    Abstract: The present invention provides purified human polynucleotides for diagnostics and therapeutics (dithp). Also encompassed are the polypeptides (DITHP) encoded by dithp. The invention also provides for the use of dithp, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing dithp for the expression of DITHP. The invention additionally provides for the use of isolated and purified DITHP to induce antibodies and to screen libraries of compounds and the use of anti-DITHP antibodies in diagnostic assays. Also provided are microarrays containing dithp and methods of use.
    Type: Application
    Filed: June 5, 2003
    Publication date: March 11, 2004
    Inventors: Scott R. Panzer, Peter A. Spiro, Steven C. Banville, Purvi Shah, Michael S. Chalup, Simon C Chang, Alice J. Chen, Steven A. D'Sa, Stefan Amshey, Christopher E. Dahl, Tam C. Dam, Susan E. Daniels, Gerard E. Dufour, Vincent Flores, Willy T. Fong, Lila B. Greenawalt, Jennifer L. Jackson, Anissa L. Jones, Tommy F. Liu, Ann M. Roseberry Lincoln, Bruce H. Rosen, Frank D. Russo, Theresa K. Stockdreher, Abel Daffo, Rachel J. Wright, Pierre E. Yap, Jimmy Y. Yu, Diana L. Bradley, Shawn R. Bratcher, Wensheng Chen, Howard J. Cohen, David M. Hodgson, Stephen E. Lincoln, Stuart E. Jackson
  • Molecules for diagnostics and therapeutics
    Publication number: 20040014087
    Abstract: The present invention provides purified human polynucleotides for diagnostics and therapeutics (dithp). Also encompassed are the polypeptides (DITHP) encoded by dithp. The invention also provides for the use of dithp, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing dithp for the expression of DITHP. The invention additionally provides for the use of isolated and purified DITHP to induce antibodies and to screen libraries of compounds and the use of anti-DITHP antibodies in diagnostic assays. Also provided are microarrays containing dithp and methods of use.
    Type: Application
    Filed: February 28, 2003
    Publication date: January 22, 2004
    Applicant: Incyte Corporation
    Inventors: David M. Hodgson, Stephen E. Lincoln, Frank D. Russo, Peter A. Albany, Steve C. Banville, Shawn R. Bratcher, Gerard E. Dufour, Howard J. Cohen, Bruce H. Rosen, Michael S. Chalup, Jennifer L. Jackson, Anissa L. Jones, Jimmy Y. Yu, Lila B. Greenawalt, Scott R. Panzer, Ann M. Roseberry Lincoln, Rachel J. Wright, Susan E. Daniels
  • Secretory molecules
    Publication number: 20030124569
    Abstract: The present invention provides purified secretory polynucleotides (sptm). Also encompassed are the polypeptides (SPTM) encoded by sptm. The invention also provides for the use of sptm, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing sptm for the expression of SPTM. The invention additionally provides for the use of isolated and purified SPTM to induce antibodies and to screen libraries of compounds and the use of anti-SPTM antibodies in diagnostic assays. Also provided are microarrays containing sptm and methods of use.
    Type: Application
    Filed: August 21, 2002
    Publication date: July 3, 2003
    Inventors: Scott R. Panzer, Peter A. Spiro, Steven C. Banville, Purvi Shah, Michael S. Chalup, Simon C. Chang, Alice Chen, Steven D'sa, Stefan Amshey, Christopher R. Dahl, Tam C. Dam, Susan E. Daniels, Gerard E. Dufour, Vincent Flores, Willy T. Fong, Lila B. Greenawalt, Jennifer L. Hillman, Anissa L. Jones, Tommy F. Liu, Ann M. Roseberry, Bruce H. Rosen, Frank D. Russo, Theresa K. Stockdreher, Abel Daffo, Rachel J. Wright, Pierre E. Yap, Jimmy Y. Yu, Diana L. Bradley, Shawn R. Bratcher, Wensheng Chen, Howard J. Cohen, David M. Hodgson, Stephen E. Lincoln
  • Fault detection and exclusion used in a global positioning system GPS receiver
    Patent number: 5841399
    Abstract: A fault exclusion (FE) system for a global positioning system (GPS) receiver which upon detection of a faulty satellite, for example, by a fault detection (FD) system, such as a receiver autonomous integrity monitoring (RAIM) system. The FE system computes the test statistics for all satellites and ranks the satellites in descending order of their test statistics. The FE system excludes data from the satellites one at a time starting with the satellites at the top of the list. Should a subsequent satellite anomaly be detected, the FE system excludes satellites based on the test statistics computed for the previous satellite anomaly condition. The FE system proceeds down the list until the fault detection condition is cleared or the list is exhausted without affecting the availability of the FD system.
    Type: Grant
    Filed: April 10, 1997
    Date of Patent: November 24, 1998
    Assignee: AlliedSignal Inc.
    Inventor: Jimmy Y. Yu